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Signal transduction of 2m-induced expression of VCAM-1 tially manifests with carpal tunnel syndrome, bone cysts
and COX-2 in synovial fibroblasts. only near joints, synovial hypertrophy, and spondylo-
Background. 2 microglobulin (2m) amyloidosis is a destruc- arthropathy [1]. Excretion of 2m occurs exclusively intive articular disease affecting dialysis patients. We have demon-
the kidney, and the removal with dialysis cannot keepstrated that 2m increases the expression of vascular cell adhe-
up with daily production [2]. As a result, patients with ad-sion molecule (VCAM-1) and cyclooxygenase-2 (COX-2) in
human osteoarthritic synovial fibroblasts (SFLs). vanced renal failure and those on dialysis have serum
Methods. To determine the cell signaling pathways, SFLs levels 15 to 30 times greater than normal. However,
were incubated with 2m in the presence or absence of various serum levels do not rise further with increasing time oninhibitors for 24 hours. Intracellular calcium ([Ca2]i) was mea-
dialysis [3], suggesting that 2m accumulates in othersured by fluorometric techniques and vascular cell adhesion
molecule-1 (VCAM-1) and cyclooxygenase-2 (COX-2) expres- body compartments. One potential compartment is the
sion was determined by immunohistochemistry and Western joint space, as 2m can freely diffuse through the synovial
blotting. membrane, and synovial fluid concentrations of 2m alsoResults. 2m increased [Ca2]i levels in a dose dependent are elevated [4]. In addition, the cartilage and synovialmanner (P  0.05) in SFLs. BAPTA-AM, a [Ca2]i chelator,
membrane in the joint space are the first and predomi-completely inhibited 2m-induced expression of VCAM-1 and
COX-2. U73122 [phospholipase C (PLC) inhibitor] or 2-APB nant sites of deposition of 2m amyloid fibrils [5].
[specific inhibitor of inositol 1,4,5-trisphosphate (IP3)-induced The mechanism by which retention of 2m leads to amy-
[Ca2]i release] completely blocked the 2m-induced increase loid fibril formation in cartilage and synovium, and thein [Ca2]i and the up-regulation of VCAM-1 and COX-2. How-
resultant joint destruction is not completely understood.ever, pretreatment with staurosporin, a protein kinase C in-
Interestingly, some of the clinical symptoms observed inhibitor, had no effect. Disruption of the actin cytoskeleton by
treatment with cytochalasin D or latrunculin A blocked 2m 2m amyloidosis (A2m) are similar to rheumatoid ar-
up-regulation of VCAM-1 and COX-2. Finally, cells treated thritis, and thus many of the pathogenic mechanisms in
with phosphatidylinositol-3 kinase (PI-3 kinase) inhibitors
rheumatoid arthritis may also be important in A2m. Inwortmannin or LY294002 also failed to express VCAM-1 and
rheumatoid arthritis, cytokines, metalloproteinases, andCOX-2.
Conclusions. These results demonstrate that IP3-mediated adhesion molecules such as vascular cell adhesion mole-
[Ca2]i release, PI-3 kinase, and actin cytoskeleton reorganiza- cule-1 (VCAM-1) are released in the joint space, leading
tion are involved in 2m-induced expression of VCAM-1 and to tissue degradation [6–10]. Although past dogma wasCOX-2 in human SFLs. Understanding the potential pathways
that inflammatory cells were the source of these sub-by which 2m exerts its inflammatory-like effects may lead to
stances and the cause of the joint destruction, current evi-the development of future therapies.
dence suggests the synovial intimal lining fibroblast-like
cells (SFLs) also can release these substances and may
2-microglobulin (2m) amyloidosis is a destructive ar- be more important in the early pathogenesis of the dis-
ticular disease that causes significant morbidity and mor- ease [6]. Pathologic studies of 2m amyloid deposits have
tality in patients on long-term dialysis. The disease ini- demonstrated staining for cytokines, adhesion molecules
such as VCAM-1 and metalloproteinases [11–13]. How-
ever, unlike rheumatoid arthritis, there is a paucity of in-Key words: intracellular calcium, actin cytoskeleton, gene expression,
cell signaling, articular disease, phosphatidylinositol-3 kinase. flammatory infiltrates with the exception of macrophages
that appears late in the disease course [14]. Thus, theReceived for publication March 6, 2001
synovial fibroblast also may be important in the pathogen-and in revised form July 27, 2001
Accepted for publication September 10, 2001 esis of the joint destruction observed in 2m amyloidosis.
We have previously demonstrated that 2m induced 2002 by the International Society of Nephrology
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the release of matrix metalloproteinase-1 (MMP-1) and phenoxy) ethane-NN-NN-tetraacetic acid; Calbiochem,
San Diego, CA, USA] was used to chelate intracellularVCAM-1 from human synovial fibroblasts [15, 16]. In
monocyte/macrophages, alteration of2m with advanced Ca2. U73122 (5 mol/L; Biomol, Plymouth Meeting,
PA, USA) was used to inhibit phospholipase C (PLC).glycation end-products (AGE-2m) leads to enhanced
release of cytokines compared to 2m not altered with U73343 (5 mol/L; Biomol), an isoform of U73122 that
binds to PLC but fails to inhibit it, was used to determineAGE [17, 18]. However, the opposite is true in synovial
fibroblasts, where 2m, but not AGE-2m, leads to the the specificity of PLC inhibition. 2-APB (2-aminoeth-
oxydiphenylborate), a more specific and diffusible ino-release of the proteins MMP-1 [15], VCAM-1 [16], and
cyclooxygenase-2 (COX-2; unpublished observations). sitol 1,4,5-trisphosphate (IP3) inhibitor, was also used
(75mol/L; Calbiochem) in the experiments. Cytochalal-This supports the hypothesis that the synovial fibroblast
may be affected early in the course of the disease, prior sin D (1 mol/L; Calbiochem) and Latrunculin A (1
mol/L; Calbiochem) were used to disrupt the actin cy-to the in situ alteration of the amyloid deposits with
AGE [19]. In addition to our work, others have found toskeleton reorganization. To examine the involvement
of protein kinase C in the response to 2m, staurosporin2m-induced MMP-3 [20] and COX-2 expression in hu-
man synovial fibroblasts [21], although the effect of (50 nmol/L; Calbiochem) was used as an inhibitor. To
test if COX-2 up-regulation is blocked by prostaglandinAGE-2m was not evaluated in these reports [reviewed
in 22]. This indicates that 2m by itself, even in the ab- inhibitors, indomethacin, a non-specific cyclooxygenase
inhibitor (10mol/L; Sigma), was used. Finally, wortman-sence of cellular infiltrates, may lead to the release of
these “inflammatory” mediators of joint destruction. The nin (10 mol/L; Calbiochem) and LY294002 (10 mol/L;
Sigma) were used to determine if phosphatidylinositol-3present study evaluates the cell signaling mechanism by
which 2m induces the production of these mediators, (PI-3) kinase is involved in 2m-induced COX-2 and
VCAM-1 expression in SFLs.focusing on the expression of VCAM-1 and COX-2.
The concentrations of these inhibitors used in the ex-
periments were optimized by determining cell viability
METHODS
using nuclear dye 7-Aminoactinomycin (7-AAD; Molec-
Isolation and culture of human synoviocytes ular Probes). Briefly, after incubation with various inhib-
itors for 24 hours, SFLs were dispensed into culture tubesHuman synovium was obtained from patients under-
going total knee or hip replacement for osteoarthritis, and 7-AAD (5 g/mL) was added. The percentage of
viable cells was determined by flow cytometry (Bectonas approved by our local Institutional Review Board.
Synovial tissue was minced, digested with collagenase Dickson FACScan). The maximum concentration of in-
hibitor at which there was greater than 70% viability(Wako, Richmond, VA, USA), followed by trypsin
(Sigma, St. Louis, MO, USA). The supernatant was col- was used in experiments, as this is the viability of cells
after trypsinization with the routine cell culture passagelected, collagenase activity quenched, and cells pelleted
and placed in a T-25 flask in Dulbecco’s modified Eagle’s technique.
medium (DMEM; Gibco, Gaitherburg, MD, USA) with
Intracellular Ca2 imaging20% fetal bovine serum (FBS). The cells were character-
ized by immunohistochemistry, flow cytometry and bio- To determine the effects of 2m and various inhibitors
on cytosolic free Ca2 concentration ([Ca2]i), SFLs werechemical staining as previously described [15, 16]. At
passage one, approximately 90% of cells were macro- grown on 35 mm glass bottom microwell dishes (MatTek
Corp., Ashland, MA, USA) under the same conditionsphage-like and 10% fibroblast-like cells. As passages
continued, the proportion of fibroblasts increased to 80– as described above. Prior to the experiment, cells were
loaded with 3 mol/L fura 2-AM (Molecular Probes, Eu-90% by pass 3, and thus all experiments were performed
on passages 5 to 6 to ensure pure fibroblast-like cells. gene, OR, USA), a fluorescent [Ca2]i chelator, in Hank’s
balanced saline solution (HBSS) for 30 minutes at 37C.The human synovial fibroblast-like cells (SFLs) were
then cultured at 5  104 cells/mL in DMEM containing Cells were rinsed and incubated for an additional 15 min-
utes with HBSS alone to allow for complete de-esterifi-20% fetal bovine serum (FBS), 100 U/mL penicillin G
(Sigma) and maintained in a 95%/5% air/CO2 humidified cation of the fluorescent probe. A ratiometric video-image
analysis apparatus (Intracellular Imaging, Inc., Cincin-environment at 37C until confluent (3 to 4 days). 2m
was isolated from dialysis ultrafiltrate and found free of nati, OH, USA) was used to determine changes in [Ca2]i.
This apparatus utilizes a Xenon lamp equipped withAGE products as previously described [15, 16].
To determine the roles of intracellular Ca2 and actin quartz collector lenses that illuminates the cells through
a computer-controlled shutter and filter changer con-cytoskeleton reorganization on 2m-induced expression
of VCAM-1 and COX-2, cells were treated with 2m taining two interference filters (340 and 380 nm). Follow-
ing excitation, emitted light passes through a 430 nm di-(25 g/mL) for 24 hours in the presence or absence of
various agents: BAPTA-AM [10mol/L, 1,2-bis (o-amino- chroic mirror, is filtered at 510 nm, and imaged by an
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integrating charge-coupled device video camera. The ra- was blocked in Tris buffered saline containing 5% nonfat
dry milk and 0.05% Tween-20 (TBST) for one hour, thentio of consecutive frames obtained at 340 and 380 nm is
determined, and the [Ca2]i in each cell calculated from incubated with 1 g/mL goat antibodies to COX-2 or
VCAM-1 (Santa Cruz Biotechnology) overnight at 4C.this ratio by comparison to a fura-2 free acid standard
curve as previously described [23]. The net [Ca2]i re- The membrane was washed with TBST buffer and then
incubated with donkey anti-goat IgG peroxidase conju-sponse was calculated by determining the difference be-
tween baseline and peak calcium levels in response to gate (1:5000 dilution). The immunodetection was accom-
plished using the Enhanced Chemiluminescence Kit (NENthe addition of 2m in the presence or absence of various
inhibitors. Bovine serum albumin (BSA) was used as a Life Science Products, Boston, MA, USA). The band in-
tensity was analyzed by scanning densitometry (Molecu-control for non-specific findings.
lar Analysis; Bio-Rad).
Immunocytochemistry and fluorescence microscopy
Statistical analysisSynovial fibroblasts were grown on four-well chamber
slides (Nalge Nunc International, Naperville, IL, USA) The difference of intracellular calcium levels in re-
sponse to 2m was compared by analysis of varianceand incubated with various reagents for 24 hours. The
cells were washed in phosphate buffered saline (PBS) (ANOVA) with Fisher’s post-hoc analysis. Statistical
significance of difference in expression of COX-2 andand fixed in 4% paraformaldehyde in PBS for 15 minutes.
Cells were then permeabilized with 0.2% Triton-X100 VCAM-1 was performed by one-way ANOVA. Compar-
isons were made between densitometric analysis of West-in PBS for five minutes followed by two washes of PBS.
To reduce the non-specific binding, cells were treated with ern blots of treated and control cells. The results are
expressed as mean  SEM, with P  0.05 considered sig-3% donkey serum in PBS for 20 minutes. For COX-2
or VCAM-1 expression, cells were incubated with 1:100 nificant (StatView; SAS Institute, Inc., Cary, NC, USA).
primary antibodies against either COX-2 or VCAM-1
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) for
RESULTS
one hour in a humidified chamber at 37C, followed by
2m modulates intracellular calcium levels in SFLsincubation with the appropriate Texas Red (TR)-con-
jugated secondary antibodies (1:50; Jackson Immuno- To determine if [Ca2]i changed in response to 2m,
fura 2-loaded SFLs were imaged. Baseline [Ca2]i levelResearch Laboratories, West Grove, PA, USA) for 30
minutes. The organization of actin cytoskeleton was was measured for one minute before 2m was added to
the cells and the net change after 2m determined. Asexamined by staining the cells with the F-actin probe
BODIPY phalloidin (Molecular Probes) for 30 min- shown in Figure 1A, 2m induced a rapid increase in
[Ca2]i within 40 seconds of onset and [Ca2]i level wasutes at 37C. Negative controls were performed by substi-
tuting the primary antibody with PBS in experiments. back to baseline by four minutes. Figure 1B showed that
2m induced a dose dependent increase in the [Ca2]iImages were recorded on a Digital camera (Photometrics
series 300 system) using a Nikon Diaphot 200 microscope level (P  0.05). The addition of a similar amount of
BSA had no effect on [Ca2]i response. To examine whe-through 20 or 60 objective (1.4 numerical aperture).
Images were processed on a MetaMorph Imaging System ther the PLC and IP3 pathways are involved in 2m-
induced [Ca2]i response, SFLs were pretreated with(Universal Imaging Corporation, Westchester, PA, USA).
U73122 (5mol/L) or 2-APB (75mol/L) for 30 minutes
Western blot analysis before the addition of 2m. As shown in Figure 1C, both
IP3 inhibitors completely blocked 2m-induced [Ca2]iSynovial fibroblasts were grown in a T-75 flask and
incubated with various reagents for 24 hours. Cells were release (P  0.05). However, pretreating SFLs with a
PKC inhibitor (staurosporin 50 nmol/L) had no effectthen washed with cold PBS and incubated with ice-cold
lysis buffer containing 5 mmol/L HEPES (pH 7.9), 150 on 2m-induced increase in [Ca2]i.
mmol/L NaCl, 26% glycerol (vol/vol), 1.5 mmol/L MgCl2,
IP3-mediated intracellular calcium release and PI-30.2 mol/L ethylenediaminetetraacetic acid (EDTA),
kinase are responsible for the 2m-induced expression0.5 mmol/L dithiothreitol (DTT) and 0.5 mmol/L phenyl-
of VCAM-1 and COX-2 in SFLsmethylsulfonyl fluoride (PMSF). Whole cell lysates
(20 g) were mixed with equal volume of 2 Laemmli Consistent with our previous findings [16], 2m induced
a dramatic increase in intensity of immunostaining forsample buffer. The mixture and prestained molecular
weight markers were boiled for five minutes and sepa- VCAM-1 (Fig. 2 A, B). A similar pattern [21] was ob-
served for COX-2 (Fig. 3 A, B) in SFLs. To determinerated by 10% SDS-polyacrylamide gel electrophoresis
(SDS-PAGE). Proteins were electrophoretically trans- the role of [Ca2]i in the up-regulation of VCAM-1 and
COX-2 expression in response to 2m, cells were treatedferred to a polyvinylidene difluoride (PVDF) membrane
(Millipore Corp., Bedford, MA, USA). The membrane with 2m (25 g/mL) for 24 hours in the presence or
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Fig. 1. 2-microglobulin (2m) modulates intracellular calcium levels in synovial fibroblast-like cells (SFLs). Cells were loaded with 3 mol/L fura
2-AM, a fluorescent intracellular calcium ([Ca2]i) chelator and baseline [Ca2]i level determined for one minute. Then 2m (10, 25 or 50 g/mL)
or bovine serum albumin (BSA 25g/mL) was added to the cells and the [Ca2]i response (y-axis) was calculated by determining the difference
between baseline and peak calcium levels. (A) Representative experiment with Ca2 imaging illustrating response of SFLs to 2m (25 g/mL).
The peak [Ca2]i response occurred within 40 seconds after addition of 2m (arrow). (B) 2m induced a dose dependent increase in [Ca2]i
concentrations, whereas BSA did not. #Different from 2m (10 g/mL); *different from cells treated with BSA, P  0.05. (C) Influence of various
inhibitors in 2m-induced [Ca2]i response in SFLs. Cells were pretreated with U73122 (PLC inhibitor, 5 mol/L), 2-APB (IP3 inhibitor, 75 mol/L)
or staurosporin (PKC inhibitor, 50 nmol/L) for 30 minutes before the addition of 2m (25 g/mL) and the [Ca2]i response was measured. U73122
and 2-APB completely blocked 2m-induced increase in [Ca2]i, whereas staurosporin had no effect (*different from cells treated with 2m alone,
P  0.05).
absence of BAPTA-AM (10 mol/L), a membrane-per- phosphatidylinositol 4,5-bisphosphate by PLC, we next
determined the role of the PLC pathway in 2m-inducedmeable Ca2 chelator. BAPTA-AM completely abol-
ished the2m-induced expression of VCAM-1 (Fig. 2 C, F) response in SFLs. Cells treated with U73122 (5 mol/L),
a specific inhibitor of PLC, failed to up-regulate VCAM-1and COX-2 (Fig. 3 C, F) in SFLs. These data indicate
that an increase in [Ca2]i level is required for 2m- (Fig. 2 D, G) and COX-2 (Fig. 3 D, G) expression in
response to 2m. However, U73343 (5 mol/L), an iso-induced up-regulation of VCAM-1 and COX-2 expres-
sion in SFLs. form of U73122 that binds to PLC but does not inhibit
it, had no effect on 2m-induced expression of VCAM-1Since intracellular Ca2 release is activated by D-myo-
inositol 1,4,5-trisphosphate (IP3), which is cleaved from (Fig. 2 E, H) and COX-2 (Fig. 3 E, H). Cells treated
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with 2-APB, a specific inhibitor of IP3-induced [Ca2]i 3 in C, G, K). However, these inhibitors of actin cytoskel-
eton reorganization abolished the2m-induced VCAM-1release, also failed to up-regulate VCAM-1 (Fig. 2I) and
COX-2 (data not shown) expression in response to 2m. (Fig. 4, column 4 in D, H, L) and COX-2 expression
(Fig. 5, column 4 in D, H, L) in SFLs. These data indicateActivation of PLC results in generation of IP3 and diacyl-
glycerol (DAG), and DAG and Ca2 are important in that the reorganization of actin cytoskeleton is essential
for the 2m-induced expression of VCAM-1 and COX-2the activation of protein kinase C (PKC). We therefore
examined the involvement of PKC in2m-induced expres- in SFLs.
To confirm the data obtained from immunohistochem-sion of VCAM-1 and COX-2. SFLs were treated with
2m in the presence or absence of the PKC inhibitor istry, Western blotting of cell extracts from control and
2m-treated cells incubated with various inhibitors wasstaurosporin (50 nmol/L) for 24 hours. Inhibition of PKC
had no effect on 2m-induced expression of VCAM-1 performed. Cells also were treated with 100 ng/mL tumor
necrosis factor-	 (TNF-	) for 24 hours as a positive con-(Fig. 2 J, M) or COX-2 (Fig. 3 J, M), indicating that
activation of PKC is not required for up-regulation of trol for up-regulation of VCAM-1 and COX-2. Figure
6 A (COX-2) and B (VCAM-1) are representative West-VCAM-1 and COX-2 by 2m. To test whether 2m-
induced COX-2 expression is blocked by a prostaglan- ern blots from single experiments, and Figure 6C is com-
din inhibitor, SFLs were treated with indomethacin (10 bined densitometry data of three experiments with the
mol/L; Sigma) in the presence of 2m for 24 hours. condition numbers corresponding to that in Figure 6 A
Indomethacin abolished up-regulation of COX-2 expres- and B. Densitometry analysis showed that 2m increased
sion in response to 2m in SFLs (Fig. 3I). Finally, we COX-2 and VCAM-1 expression by 6.8- and 3.3-fold
explored the role of PI-3 kinase in the response of SFLs (COX-2 
 12.21  2.8, VCAM-1 
 17.12  2.0, P 
to 2m. Cells were treated with 2m in the presence or 0.05) over control (COX-2 
 1.77  0.3, VCAM-1 

absence of the PI-3 kinase inhibitors wortmannin (10 5.2  0.9, respectively) in SFLs. Figure 6C illustrates
mol/L) or LY294002 (10 mol/L) for 24 hours. Cells that the calcium chelator BAPTA-AM (COX-2
 3.22
treated with wortmannin or LY294002 failed to up- 0.80 and VCAM-1 
 5.93  0.95) and PLC inhibitor
regulate VCAM-1 (Fig. 2, K & N, L & O) and COX-2 U73122 (COX-2 
 3.44  0.70 and VCAM-1 
 5.5 
(Fig. 3, K & N, L & O) in response to 2m. These data 0.80) abolished the response of COX-2 and VCAM-1 to
suggest that IP3-mediated Ca2 release from intracellular 2m, whereas the inactive isoform U73343 had no effect
stores is indeed responsible for the altered expression on 2m-induced expression of COX-2 and VCAM-1
of VCAM-1 and COX-2 in response to 2m in SFLs. In (COX-2 
 10.23  1.40 and VCAM-1 
 13.9  1.85,
addition, PI-3 kinase also is involved in the 2m-induced P  0.05). Disruption of actin cytoskeleton with cyto-
response in SFLs. chalasin D suppressed 2m-induced increases in COX-2
and VCAM-1 expression (COX-2 
 5.17  0.8 and
2m-induced expression of VCAM-1 and COX-2 is VCAM-1 
 5.77  0.7, P  0.05). Blocking PI-3 kinase
dependent on actin cytoskeleton reorganization with wortmannin also inhibited up-regulation of COX-2
To test the role of the organization of the actin cyto- and VCAM-1 in response to 2m (COX-2 
 3.63  0.5
skeleton in 2m-induced up-regulation of VCAM-1 and and VCAM-1
 4.95 0.7, P 0.05), whereas inhibition
COX-2, SFLs were treated with either 1 mol/L cytocha- of PKC with staurosporin had no effect on 2m-induced
lasin D or 1 mol/L latrunculin A in the presence or ab- response (COX-2 
 10.43  1.10 and VCAM-1 

sence of 2m (25g/mL) for 24 hours. Treatment of SFLs 16.68  2.50, P  0.05).
with either cytochalasin D or latrunculin A changed the
shape of the cells and caused a loss of stress fibers (Figs.
DISCUSSION4 and 5, column 1 in A, E, I) with no effect on basal
This study determines the cell signaling pathways re-expression of VCAM-1 (Fig. 4, column 2 in B, F, J) and
sponsible for the up-regulation of VCAM-1 [16] andCOX-2 (Fig. 5, column 2 in B, F, J). This disruption of
COX-2 [21] in human synovial fibroblasts. Up-regulationmicrofilaments with cytochalasin D or latrunculin A was
not different in the presence of2m (Figs. 4 and 5, column of COX-2 is considered the mechanism through which

Fig. 2. Roles of intracellular calcium ([Ca2]i) and phosphatidylinositol 3 (PI-3) kinase in 2-microglobulin (2m)-induced expression of vascular
cell adhesion molecule in synovial fibroblasts (SFLs). Cells treated with 2m for 24 hours had increased expression of VCAM-1 (A, B). Cells were
also treated with various blockers in the absence or presence of 2m (25 g/mL) for 24 hours: 10 mol/L BAPTA-AM (Ca2 chelator, C, F ); 5
mol/L U73122 (PLC inhibitor, D, G); 5 mol/L U73343 (negative control for PLC inhibitor, E, H ); 75 mol/L 2-APB (IP3 inhibitor, I ); 50
nmol/L staurosporin (PKC inhibitor, J, M); 10 mol/L wortmannin or LY294002 (PI-3 kinase inhibitor, K, N, L, O). Images were recorded on
Digital camera and processed on a MetaMorph Imaging System (20). The results demonstrate that [Ca2]i, PLC and PI-3 kinase, but not PKC,
are essential for 2m-induced VCAM-1 expression.
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Fig. 3. Roles of [Ca2]i and PI-3 kinase in 2m-induced expression of COX-2 in SFLs. Cells treated with 2m for 24 hours had increased expression
of COX-2 (A, B). Cells also were treated with various blockers in the absence or presence of 2m (25 g/mL) for 24 hours: 10 mol/L BAPTA-
AM (Ca2 chelator, C, F ); 5 mol/L U73122 (PLC inhibitor, D, G); 5 mol/L U73343 (negative control for PLC inhibitor, E, H ); 10 mol/L
indomethacin (COX inhibitor, I ); 50 nmol/L staurosporin (PKC inhibitor, J, M); 10 mol/L wortmannin or LY294002 (PI-3 kinase inhibitor, K,
N, L, O). Images were recorded on Digital camera and processed on a MetaMorph Imaging System (20). The results demonstrate that intracellular
calcium, PLC and PI-3 kinase, but not PKC, are essential for 2m-induced COX-2 expression.
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Fig. 4. Dependence of 2m-induced expression of VCAM-1 on actin cytoskeleton reorganization in SFLs. Cells were treated with or without 2m
(25 g/mL) for 24 hours and stained for F-actin (A, C ) and VCAM-1 (B, D). SFLs were also treated with 1 mol/L cytochalasin D or latrunculin
A, which disrupt actin cytoskeleton reorganization, in the absence (E, F, I, J ) or presence of 2m (G, H, K, L) for 24 hours and stained for F-actin
and VCAM-1. Images were recorded on a Digital camera and processed on a MetaMorph Imaging System (20). 2m-induced VCAM-1 expression
was attenuated by these inhibitors of the actin cytoskeleton.
cellular prostaglandin levels are elevated in inflamma- arrangement and PI-3 kinase. Intracellular calcium is an
important second messenger within many cells, regulat-tory processes, as opposed to COX-1, which is constitu-
tively expressed [24]. Prostaglandins are important medi- ing cell growth, cell differentiation, cell survival, and
enzyme and gene expression [26, 27]. The increase inators in both rheumatoid arthritis and osteoarthritis, and
inhibition of prostaglandins with non-steroidal anti-inflam- intracellular calcium can be induced via activation of
phospholipase C (PLC), which hydrolyzes PIP2 to gener-matory drugs gives symptomatic relief to arthritic pa-
tients [24]. Immunostaining of pathologic specimens ob- ate diacylglycerol (DAG) and IP3. IP3 then binds to a
receptor linked to a channel on the endoplasmic reticu-tained from patients with 2m amyloidosis also reveal
positive staining for MMP-1, and VCAM-1 [11–13]. Thus, lum, inducing release of Ca2. PLC also can activate
protein kinase C (PKC) through DAG [28]. The IP3-the present study as well as previous findings [15, 16],
confirm that 2m may directly release these “inflamma- mediated intracellular Ca2 pathway has been implicated
in prostaglandin production in osteoblasts [29]. How-tory” mediators from synovial fibroblasts, and may par-
tially explain the symptomatic relief of A2m patients ever, PKC signaling pathway is important in the matrix
metalloproteinase release from synovial fibroblasts inwho receive immunosuppressive drugs post renal trans-
plant [25]. However, a more targeted approach to the response to basic calcium phosphate crystals [30] and
macrophage migration inhibitory factor [31]. Identifyingtreatment of this disease is desired, which requires a
better understanding of the signaling pathways involved. the specific processes is important, as there is a rapid
increase in the number of pharmacologic agents to blockThe present study demonstrated that 2m induced the
expression of VCAM-1 and COX-2 through changes in these various pathways. In the present study, U73122,
an inhibitor of PLC, abolished expression of VCAM-1IP3-mediated intracellular calcium, actin cytoskeleton re-
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Fig. 5. Dependence of 2m-induced expression of COX-2 on actin cytoskeleton reorganization in SFLs. Cells were treated with or without 2m
(25 g/mL) for 24 hours and stained for F-actin (A, C ) and COX-2 (B, D). SFLs also were treated with 1 mol/L cytochalasin D or latrunculin
A, which disrupt actin cytoskeleton reorganization, in the absence (E, F, I, J) or presence of 2m (G, H, K, L) for 24 hours and stained for F-actin
and COX-2. Images were recorded on a digital camera and processed on a MetaMorph Imaging System (20). 2m-induced COX-2 expression
was attenuated by these inhibitors of the actin cytoskeleton.
and COX-2 in response to 2m in SFLs, whereas the non- [Ca2]i also can regulate proteins that have diverse effects
on actin assembly including polymerization [37] and theinhibiting isoform, U73343 [32], had no effect. Moreover,
a specific inhibitor of IP3-induced intracellular calcium activation of actin severing proteins such as gelsolin [38].
[Ca2]i also modulates the linkage between cytoskeletonrelease (2-APB) also blocked2m-induced VCAM-1 and
COX-2 expression. In contrast, staurosporin, a PKC inhib- and integrins [39], which form the ligand for VCAM-1
[40]. The expression of MMP-1 and MMP-3 in synovialitor, did not alter 2m-induced VCAM-1 and COX-2 ex-
pression in synovial fibroblasts, indicating that indeed IP3- fibroblasts is dependent on actin cytoskeleton reorgani-
zation [41, 42]. We also have previously demonstrated thatmediated intracellular calcium release, rather than PKC,
is responsible for 2m-induced expression of VCAM-1 actin cytoskeleton reorganization is necessary for shear
stress-induced COX-2 expression in osteoblasts [43]. Inand COX-2 in SFLs. We also found another protein
kinase, PI-3 kinase, to be important in the signal trans- the current study, disruption of the actin cytoskeleton re-
organization with cytochalasin D or latrunculin A abol-duction of 2m in SFLs. PI-3 kinase has been implicated
in various cellular signaling pathways including regula- ished expression of VCAM-1 and COX-2 in response
to 2m in SFLs, supporting a critical role for the actintion of intracellular calcium and actin cytoskeleton [33].
Modification of cell shape via reorganization of the cytoskeleton in mediating these effects.
The mechanism by which 2m initiates these signalingactin cytoskeleton and the modulation of cell adhesion
[34, 35] is crucial for tissue morphogenesis, cell migra- cascades is unclear, as there is no known cell membrane
receptor for 2m. While 2m is non-covalently linked totion, and invasion. Changes in cell morphology lead to
specific signaling from cell adhesion receptors and a con- the light chain of MHC-I complex when 2m is synthe-
sized from within the cell, whether exogenous 2m cansequent change of gene expression [36]. Increases in
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identified in the present study. Thus, it is possible that
the association of added 2m with MHC-I in SFLs in-
duced the signal transduction pathways observed in the
present study, but confirmation is required.
In summary, we show that 2m-induced expression of
VCAM-1 and COX-2 in human synovial fibroblasts is
dependent on IP3-mediated intracellular Ca2 release and
actin cytoskeleton reorganization. In addition, PI-3 kinase
is involved in the signal transduction pathway of 2m-
induced response. Recent evidence suggests that a num-
ber of transcription factors, including nuclear factor-B
(NF-B) and c-fos play a pivotal role in the regulation
of expression of many genes implicated in rheumatoid
arthritis, such as TNF-	, MMP-1, VCAM-1 and COX-2
[47], although our preliminary data indicate that 2m
cannot activate either NF-B or c-fos in SFLs (Chen,
unpublished data). Further studies are necessary to iden-
tify the transcription factor responsible for 2m-induced
expression of VCAM-1 and COX-2 in SFLs. Neverthe-
less, our current study provides evidence that changes in
intracellular calcium and actin cytoskeleton play a critical
role in the signaling pathway in response to2m in human
synovial fibroblasts. Fully understanding the mechanisms
and consequences of 2m–induced inflammatory-like ef-
fects, and how these interact with the inflammatory ef-
fects of AGE-2m in monocyte/macrophages to induce
Fig. 6. Western blot analysis of 2m-induced VCAM-1 and COX-2 the pathology observed in 2m amyloidosis will likelyexpression in synovial fibroblasts in the presence of various cell signaling
require an animal model. Unfortunately, this does notinhibitors. Cells were treated with 2m in the presence of 10 mol/L
BAPTA, 5mol/L U73122, 5 mol/L U73343, 1mol/L cytochalasin D, yet exist. However, it does point to the importance in
50 nmol/L staurosporin, 10 mol/L wortmannin, or TNF-	 (100 ng/mL, fully evaluating anti-inflammatory agents as potentialpositive control) for 24 hours. Cells were lysed and Western blotting
therapies for this disease, and to continue the quest ofwas performed with VCAM-1 or COX-2 antibody using equal loading
of total protein concentration of 20 g/lane. The band intensity was maximizing the dialytic removal of 2m.
analyzed by scanning densitometry. (A) COX-2 expression in synovial
fibroblasts. (B) VCAM-1 expression in synovial fibroblasts. (C ) Mean
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